Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

HL-1 is the adult murine cardiac cell line that can be passaged repeatedly in vitro without losing differentiated phenotype. The present study was designed to characterize the rapidly activating delayed rectifier potassium current, I (Kr), endogenously expressed in HL-1 cells using the whole-cell patch-clamp technique. In the presence of nisoldipine, depolarizing voltage steps applied from a holding potential of -50 mV evoked the time-dependent outward current, followed by slowly decaying outward tail current upon return to the holding potential. The amplitude of the current increased with depolarizations up to 0 mV but then progressively decreased with further depolarizations. The time-dependent outward current as well as the tail current were highly sensitive to block by E-4031 and dofetilide (IC(50) of 21.1 and 15.1 nM, respectively) and almost totally abolished by micromolar concentrations of each drug, suggesting that most of the outward current in HL-1 cells was attributable to I (Kr). The magnitude of I (Kr) available from HL-1 cells (18.1 +/- 1.5 pA pF(-1)) was sufficient for reliable measurements of various gating parameters. RT-PCR and Western blot analysis revealed the expression of alternatively spliced forms of mouse ether-a-go-go-related genes (mERG1), the full-length mERG1a and the N-terminally truncated mERG1b isoforms. Knockdown of mERG1 transcripts with small interfering RNA (siRNA) dramatically reduced I (Kr) amplitude, confirming the molecular link of mERG1 and I (Kr) in HL-1 cells. These findings demonstrate that HL-1 cells possess I (Kr) with properties comparable to those in native cardiac I (Kr) and provide an experimental model suitable for studies of I (Kr) channels.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00232-010-9257-2DOI Listing

Publication Analysis

Top Keywords

hl-1 cells
20
outward current
12
rapidly activating
8
activating delayed
8
delayed rectifier
8
rectifier potassium
8
current
8
potassium current
8
current hl-1
8
holding potential
8

Similar Publications

CRISPR activation to repair ECG abnormalities caused by a FLNC truncating variant in mice.

Eur Heart J

August 2025

Myocardial Homeostasis and Cardiac Injury Programme, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.

Background: Truncating variants in the Filamin C gene (FLNCtv) are a frequent cause of genetic dilated cardiomyopathy (DCM) and non-dilated left ventricular cardiomyopathy (NDLVC), both characterized by arrhythmic complications and increased risk of sudden cardiac death. Currently, no gene-specific therapies exist for FLNCtv-induced cardiomyopathy. CRISPR activation (CRISPRa), which upregulates gene expression via transcriptional activation without cutting the genome, offers a promising strategy, particularly for genes like FLNC whose large size precludes conventional AAV-based gene replacement.

View Article and Find Full Text PDF

IDHP Mitigates LPS-Induced Cardiomyocyte Injury via the GAS6/Axl-AMPK Axis: A Multi-Target Strategy Counteracting Inflammation, Oxidative Stress, and Apoptosis.

Pharmaceuticals (Basel)

August 2025

Xi'an Key Laboratory of Innovative Drug Research for Heart Failure, Faculty of Life Sciences and Medicine, Northwest University, 229 Taibai North Road, Xi'an 710069, China.

Sepsis-induced myocardial injury (SIMI) significantly contributes to sepsis-related mortality, yet effective therapies remain limited. This study investigated the cardioprotective potential of isopropyl 3-(3,4-dihydroxyphenyl)-2-hydroxypropanoate (IDHP), a bioactive metabolite from , focusing on its mechanism via the GAS6/Axl signaling axis in lipopolysaccharide (LPS)-induced myocardial injury. Using an in vitro HL-1 cardiomyocyte model, IDHP's cytotoxicity was assessed (0-20 μM).

View Article and Find Full Text PDF

Modeling atrial fibrillation (AF) is crucial for investigating its pathogenesis and developing new therapeutic strategies. To better explore the mechanisms underlying AF and promote the progress of basic research, it is particularly important to develop accurate animal models that closely simulate the progression of clinical disease. This review summarizes the methods and evaluation criteria for establishing animal and cellular AF models over the past decade, highlighting the advantages and limitations of various models to provide a reference for basic research and treatment of AF.

View Article and Find Full Text PDF

Identification and pathological significance of variants in the promoter region of ACTC1 gene in congenital ventricular septal defect.

Gene

October 2025

Department of Cardiovascular Surgery & The Institute of Cardiovascular Diseases, TEDA International Cardiovascular Hospital, Tianjin University & Chinese Academy of Medical Sciences, Tianjin 300457, China; Tianjin Key Laboratory of Molecular Regulation of Cardiovascular Diseases and Translational Me

Ventricular septal defect (VSD) is one of the most common congenital heart diseases, but the role of variants at the ACTC1 gene promoter region in VSD is unclear. We investigated variants in the promoter region of ACTC1 gene in 627 subjects (309 sporadic VSD patients and 318 healthy controls) by Sanger sequencing and 6 variants including 1 novel heterozygous variant [g.5163 T > A] were identified.

View Article and Find Full Text PDF

Background: Diabetic cardiomyopathy (DCM) is an irreversible cardiovascular complication of diabetes mellitus characterized by detrimental cardiac remodeling. Orientin, a water-soluble flavonoid present in many medicinal plants, exerts various pharmacological effects.

Objectives: To investigate the cardioprotective effects of orientin in diabetic conditions and elucidate the mechanisms associated with non-coding RNAs.

View Article and Find Full Text PDF